ClinicalTrials.Veeva

Menu

Registry for Chronic Obstructive Pulmonary Disease With Anxiety and Depression in China

C

Chinese Academy of Medical Sciences, Fuwai Hospital

Status

Unknown

Conditions

Depression
COPD
Anxiety

Study type

Observational

Funder types

Other

Identifiers

NCT03187236
2016YFC1304404A

Details and patient eligibility

About

Anxiety and depression are common comorbidities of chronic obstructive pulmonary disease (COPD). However, the exact prevalence is not known in China. COPD patients with anxiety and depression tend to have more severe symptoms and worse prognosis, but the related evidences are not strong enough. The study aim to investigate the prevalence and long-term outcome of anxiety and depression in COPD.

Enrollment

1,906 estimated patients

Sex

All

Ages

Under 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Stable chronic obstructive pulmonary disease (COPD) patients

Exclusion criteria

  • Patients with bronchial asthma or other severe pulmonary diseases or having received pulmonary surgery in 6 months
  • Patients with tumor history during past 5 years
  • Patients with COPD exacerbations during past 4 weeks
  • Participants in clinical trials
  • Patients in pregnancy or breastfeeding
  • Patients unable to complete questionaire independently
  • Patients older than 80 years old
  • Patients receiving long-term domiciliary oxygen therapy

Trial contacts and locations

1

Loading...

Central trial contact

Jiangna Han, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems